logo
China offers subsidy to promote fertility, but money can only solve part of the problem. Here's why.

China offers subsidy to promote fertility, but money can only solve part of the problem. Here's why.

Indian Express2 days ago
China's government this week announced a childcare subsidy of 3,600 yuan (about $500 or Rs 44,000) per year for every child under the age of three. The People's Daily, the Chinese Communist Party's newspaper, described it as a way of 'supporting fertility and to promote the building of a fertility-friendly society'.
China has tried similar measures locally earlier, but the policy announced on July 29 was the first time it was rolled out nationwide.
The population of China, the world's second most populous country (after India), has been contracting in recent years. There have been fewer Chinese births than deaths for three consecutive years since 2022. In fact, most parts of the world are grappling with declining Total Fertility Rates (TFR), which is the average number of children a woman is likely to bear in her lifetime.
China's neighbours South Korea and Japan have some of the lowest fertility rates globally, and Elon Musk, the world's richest man, has frequently sounded the alarm for the United States.
The Global Burden of Disease, Injuries and Risk Factors Study (GBD)-2021 estimated that globally, TFR more than halved from around 5 in 1950 to 2.2 in 2021.
This signals better education and financial independence for more women, and greater agency in making reproductive choices. Infant mortality rates have come down drastically during this period, women are living increasingly healthier lives, and couples are able to give their children a higher quality of life.
However, an extremely low TFR can have long-term consequences for societies.
These include increasingly unsustainable proportions of people in the above-60 age group and a shrinking of the working-age (15-59 years) population, leading to labour shortages, higher dependency ratios, higher taxation to fund the cost of healthcare for the large numbers of the elderly, and changes in social structures and relationships. Individuals like Musk believe that collapsing birth rates can lead to the disappearance of entire populations, and present a bigger threat to civilisation than climate change.
India's overall TFR stood at 1.91 in 2021. This is less than the 'replacement level' of 2.1, or the number of children that a woman would need to have to replace herself and her partner in the next generation. This figure assumes there will be no in- or out-migration, which is not the case in reality.
India's lowered TFR is the result of decades of government investment in family planning, changing social attitudes about family sizes, rising costs of raising children, and improvements in the education of women.
Many of these factors are common to other countries that have seen a decline in TFR. The only major region in the world with a high TFR today is sub-Saharan Africa, where medical advances have reduced child mortality, but fertility remains high due to cultural reasons, poverty, and the lack of decision-making powers for women.
As countries around the world grapple with declining fertility rates, many, like China, have introduced subsidies and tax incentives to encourage couples to have more children.
One reason for this is the understanding that the rising cost of living is a major deterrent to parenthood. Almost 4 in 10 respondents in an online survey of more than 14,000 adults in 14 countries carried out by the United Nations Population Fund and YouGov in June said financial limitations were stopping them from having the families they wanted.
However, these measures have had only a limited impact. The think tank Center for Strategic and International Studies noted in a 2023 article that 'Representative studies on the expansion of financial assistance show that the effects are positive but limited.' The article cited a 2013 study that reported that child allowances, even if doubled, lead to the probability of childbirth increasing by only 19.2%.
In 2006, demographer Peter McDonald identified two reasons for the decline in TFRs.
One, rising social liberalism, in which individuals in modern societies were re-examining social norms and institutions, and increasingly focusing on individual aspirations.
Two, the withdrawal of the welfare state in major Western economies in the 1980s and 1990s, which led to 'loss of trust in others, loss of a sense of the value of service (altruism), decline of community…and fear of failure or of being left behind'.
Both processes deprioritised having children as a mandate for living a good life, McDonald concluded.
'The solution to low fertility…lies in providing a greater sense of assurance to young women and young men that, if they marry and have children, they will be supported by the society in this socially and individually important decision,' he wrote.
McDonald also argued that incentivising policies have failed in countries like Japan and Singapore because they targeted particular types of women (like high earners) rather than reforming societal institutions.
What more can governments do to address the situation?
Guo Yanhong, deputy head of China's National Health Commission, said the new childcare subsidy 'works in tandem with related policies regarding childcare, education, employment, taxation and housing', Xinhua reported.
Supporting childbirth requires a comprehensive policy package, including financial support, parental leave, and cultural measures, Guo said.
Also, cultural shifts happen over a long time, and are often intangible and difficult to detect. Monetary support is something governments can directly control.
Anne Gauthier, professor of comparative family studies at the University of Groningen in the Netherlands, told the BBC that behind the higher-than-European-average TFR of France could be the generous social policies followed by the French Ministry of Families over the decades.
However, countries such as Finland, which have some of the most progressive policies for parental leave after childbirth, as well as subsidies, continue to see low TFRs.
While the specific context may be different in each country, it would seem that throwing money at the problem of falling TFRs can only do so much. Accompanying changes in how society treats the raising of children, and how people see work and fulfilment, are important as well.
Rishika Singh is a Senior sub-editor at the Explained Desk of The Indian Express. She enjoys writing on issues related to international relations, and in particular, likes to follow analyses of news from China. Additionally, she writes on developments related to politics and culture in India.
... Read More
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Town in mourning: Kannur bids farewell to its ‘two-rupee doctor'
Town in mourning: Kannur bids farewell to its ‘two-rupee doctor'

Time of India

timean hour ago

  • Time of India

Town in mourning: Kannur bids farewell to its ‘two-rupee doctor'

Kozhikode: Dr A K Rairu Gopal, 80, affectionately known as Kannur's 'two-rupee doctor' for his selfless medical service, passed away early Sunday at Manikkavu near Thana. He was battling age-related ailments. For over five decades, Gopal had stood as a beacon of compassion, charging just Rs 2 as consultation fee and offering free medicines to those who couldn't afford them. In an era of rising healthcare costs, he remained a lifeline for thousands of poor patients. The son of Dr A G Nambiar and A K Lakshmikutty Amma, Gopal began his practice at his home near the LIC office in Talap, where he treated patients for around three decades. Later, he continued his service at his residence 'Lakshmi' near Manikkavu. On average, he saw around 250 patients a day, with people often queuing up from dawn, including many from neighbouring districts. People from all walks of life sought his treatment. Gopal imbibed his zeal for selfless service from his father, who advised him: "If your aim is to make money, you can do any other job. But if you choose to become a doctor, do it to serve." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is this legal? Access all TV channels without a subscription! Techno Mag Learn More Undo Those words led him to keep his consultation fee nominal. Gopal is believed to have treated over 1.8 million patients in his over 50-year career. Thana resident M Shafeek, who knew him for years, recalled, "He was our beloved doctor - one of a kind. In the early years, he would start seeing patients as early as 5 am, to accommodate labourers, students, and others who had to leave early for work. His diagnosis was remarkably accurate, and he only recommended tests when absolutely necessary. The medicines he prescribed were also affordable." Even when Gopal revised his consultation fee after decades, it was raised only to Rs 10, but he never insisted on even that, ensuring his services remained accessible to all. He announced his retirement last year by pasting a handwritten message on his gate that his health was not allowing him to continue the practice. His wife P O Sakuntala, also a doctor, used to help him in his practice in the early years. He has two children, son Dr Balagopal and daughter Vidya. Chief minister Pinarayi Vijayan was among those who condoled Gopal's death, saying his willingness to serve by charging only Rs 2 as consultation fee for over half a century had brought great relief to poor patients. The funeral was held at Payyambalam in the afternoon. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !

Hypertension no bar: Insurance agency asked to pay 2L claim
Hypertension no bar: Insurance agency asked to pay 2L claim

Time of India

time2 hours ago

  • Time of India

Hypertension no bar: Insurance agency asked to pay 2L claim

Ghaziabad: Ruling that medical claims cannot be rejected on the grounds that a person has hypertension, the district consumer disputes redressal commission (DCDRC) has directed an insurance firm to pay Rs 2.1 lakh to a Ghaziabad man whose request was denied. DCDRC president Praveen Kumar Jain and members RP Singh and Shailja Sachan also ordered the insurer – Religare Health Insurance Company – to pay Kapil Anand Rs 5,000 as compensation for litigation costs and denial of the claim filed in 2019. The payment must be made within 45 days, and failure to comply will attract 6% simple interest on the outstanding amount. In a plea filed with the consumer commission, Anand said he'd bought the Rs 5-lakh policy from Religare after paying a premium of Rs 17,150 on March 3, 2019. You Can Also Check: Noida AQI | Weather in Noida | Bank Holidays in Noida | Public Holidays in Noida In Oct that year, he felt "discomfort" in his chest and was admitted to Yashoda Hospital. "… doctors diagnosed me with a blockage in the heart and I underwent the medical procedure of stenting in the heart," he said. The third-party administrator, he said, refused to pay his hospital bill of Rs 2,16,482 lakh, forcing him to pay it on his own. Religare's counsel argued before the commission that Anand did not disclose his history of hypertension at the time of buying the policy. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like She Was Everyone's Dream Girl In 90's, This Is Her Now The Latest Article Undo "The discharge slip, consultation papers, and past history of the patient mentioned that he suffered from hypertension for the last two years and he did not disclose this at the time of purchasing the policy," the counsel said, adding that any condition linked to hypertension cannot be honoured for a claim. The commission in its July 26 order cited two previous judgments by NCDRC-New Delhi to rule in favour of Anand. In the 2013 Ravindra Bindra vs National Insurance Company case, the Delhi commission had ruled that hypertension history could not be grounds for rejecting heart treatment claims, it said. In another 2013 case (Satish Chandra Madan vs Bajaj Alliance), NCDRC rejected the argument that hypertension was a chronic disease. "In the case Satish Chandra Madan Vs Bajal Alliance General Insurance Company, National Consumer Disputes Redressal Commission held that the petitioner was a patient of hypertension before securing the insurance policy. Hypertension is a common ailment that can be treated through medicines and it is not necessary that hypertension was linked to heart attack. Hypertension is a lifestyle disease and by rejecting the claim, insurance company is guilty of deficiency in service," the Ghaziabad commission said in its order. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !

Centre Cuts Prices Of 35 Essential Medicines
Centre Cuts Prices Of 35 Essential Medicines

NDTV

time3 hours ago

  • NDTV

Centre Cuts Prices Of 35 Essential Medicines

In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies. The formulations, which will now cost less, span a wide range of medicines including anti-inflammatory, cardiovascular, antibiotic, anti-diabetic and psychiatric medicines. The Ministry of Chemicals and Fertilisers notified the order based on price regulation by the NPPA. The price reductions, which apply across drugs, are expected to bring relief to consumers, particularly those managing chronic conditions. The key formulations covered by the price control order include fixed-dose combinations of Aceclofenac, Paracetamol and Trypsin Chymotrypsin, Amoxycillin and Potassium Clavulanate, Atorvastatin combinations and newer oral anti-diabetic combinations like Empagliflozin, Sitagliptin, and Metformin. The price of one Aceclofenac-Paracetamol-Trypsin Chymotrypsin tablet manufactured by Akums Drugs & Pharmaceuticals and marketed by Dr Reddy's Laboratories has now been fixed at Rs 13, while the same formulation marketed by Cadila Pharmaceuticals is now priced at Rs 15.01. Similarly, a tablet containing Atorvastatin 40 mg and Clopidogrel 75 mg, widely used for cardiovascular conditions, is priced at Rs 25.61. Oral suspensions for paediatric use - Cefixime and Paracetamol combinations - have also been included, along with critical medications like Cholecalciferol drops for Vitamin D supplementation and Diclofenac Injection, which has been priced at Rs 31.77 per ml. The official order states that retailers and dealers must display these updated price lists prominently in their premises. Failure to comply with the notified prices may attract penal provisions under the DPCO, 2013, and the Essential Commodities Act, 1955, including recovery of overcharged amounts with interest. The NPPA clarified that the prices fixed were exclusive of Goods and Services Tax (GST), which may be added, if applicable. Manufacturers are required to comply with all statutory requirements, issue updated price lists in Form V through the Integrated Pharmaceutical Database Management System and submit the information to the NPPA and state drug controllers. Any prior price orders issued for the specified formulations and manufacturers stand superseded by this latest notification. The NPPA, which functions under the Ministry of Chemicals and Fertilisers, is the drug price regulator in India, responsible for fixing and revising prices of pharmaceutical products and monitoring the prices of both controlled and decontrolled drugs.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store